Tonix Pharmaceuticals' Ceo Reveals Next-Generation Covid Vaccine Technology Chosen For Key Program

Tonix Pharmaceuticals' CEO Reveals Next-Generation COVID Vaccine Technology chosen for key program

Proactive Investors

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

Life Science Connect

Covid-19 Is Not Going to Go Away: Tonix Pharmaceuticals CEO

Bloomberg Television

Tonix Pharmaceuticals - COVID-19 Vaccine Program

HPR

Morning Business Report: Tonix Pharmaceuticals working on a COVID vaccine

Tonix Pharmaceuticals, Inc.'s (NASDAQ: TNXP) interview with Dr. Seth Lederman, MD, and CEO.

New to The Street TV

Tonix Pharmaceuticals: Reports Positive Covid Vaccine Efficacy In Animal Study

Tonix Pharmaceuticals (NASDAQ:TNXP): Working on Covid Vaccine and Test

Tonix Pharmaceuticals (TNXP) NobleCon18 Presentation Replay

Tonix Pharmaceuticals Discusses Developing COVID-19 Vaccine in Collaboration with Southern Research

Planet MicroCap

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

Emerging Growth Conference

Tonix Pharmaceuticals collaborates with Bilthoven on Mpox vaccine #health #mpox #vaccine

Proactive Investors

Tonix Pharmaceuticals buys 44 acres in Hamilton, plans vaccine production facility

Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP) interview, Mr. Seth Lederman, CEO

New to The Street TV

Tonix Pharmaceuticals prepares to tackle monkeypox outbreak with TNX-801 vaccine

Proactive Investors

Tonix Pharma CEO Seth Lederman discusses his company's COVID vaccine trials

New to The Street TV

Dr. Seth Lederman, CEO, Tonix Pharmaceuticals: Developing Novel Therapies Across a Range of Diseases

Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio

Proactive Investors

Proactive One2One Virtual Event - Tonix Pharmaceuticals

Proactive Investors

Tonix Pharmaceuticals, Inc.'s interview with Dr. Seth Lederman, MD, and CEO.

New to The Street TV